Onset of relief of dyspnoea after methacholine provocation with single doses of one inhalation of Symbicort Turbuhaler 160/4.5 mcg/inhalation, two inhalations of Ventoline via pMDI 100mcg/actuation, or placebo in adults with asthma - a randomised, double-blind, cross-over, phase IIIB study.
Study identifier:D5890C00007
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Onset of relief of dyspnoea after methacholine provocation with single doses of one inhalation of Symbicort Turbuhaler 160/4.5 mcg/inhalation, two inhalations of Ventoline via pMDI 100mcg/actuation, or placebo in adults with asthma - a randomised, double-blind, cross-over, phase IIIB study.
Medical condition
asthma
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jul 2004
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
